Brief: Karyopharm Therapeutics Inc - On February 27, 2026,Co Enters Second Amendment To Credit Agreement - SEC Filing
03/03/2026 11:31
March 3 (Reuters) - SEC Filing: KARYOPHARM THERAPEUTICS INC - ON FEBRUARY 27, 2026,CO ENTERS SECOND AMENDMENT TO CREDIT AGREEMENT - SEC FILING KARYOPHARM THERAPEUTICS INC - AMENDMENT ALLOWS CO DEFERRAL OF PAYMENTS UNTIL SEPTEMBER 2026 - SEC FILING KARYOPHARM THERAPEUTICS: AMENDMENT TO ELIMINATE REQUIREMENT THAT 50% OF FINANCING PROCEEDS BE APPLIED TOWARD INCREASING MINIMUM LIQUIDITY COVENANT Source text: [ID:n0001503802-26-000006] Further company coverage: KPTI.O ((Reuters.Briefs@thomsonreuters.com;))